Monthly Archives: July 2023

//July

Community Pharmacy England response to AIM press commentary

Chemist+Druggist have today published a second article in which the Chief Executive of the Association of Independent Multiple Pharmacies (AIM) makes a series of comments about Community Pharmacy England and other national pharmacy organisations. We are publishing our response to the commentary here and Community Pharmacy England’s Chair is writing to AIM’s Chair to seek [...]

The post Community Pharmacy England response to AIM press commentary appeared first on Community Pharmacy England.

By |July 26th, 2023|Lexpos News|Comments Off on Community Pharmacy England response to AIM press commentary

Last few days to complete the 2023/24 CPAF screening questionnaire.

73% of community pharmacies have completed the CPAF screening questionnaire. The remaining pharmacies (2,600) only have a few days left to complete it before the deadline of midnight this Sunday, 30th July 2023.   Community Pharmacy England recommends that any pharmacy owner who has yet to complete the screening questionnaire takes immediate action. It should only take [...]

The post Last few days to complete the 2023/24 CPAF screening questionnaire. appeared first on Community Pharmacy England.

By |July 25th, 2023|Lexpos News|Comments Off on Last few days to complete the 2023/24 CPAF screening questionnaire.

Parliamentary report refers to community pharmacy funding as ‘broken’ 

The Health and Social Care Committee’s Expert Panel, evaluating Government commitments made in the area of Pharmacy in England, has been published. Community Pharmacy England had previously submitted a full and detailed response which can be read here. In addition to this, we attended a roundtable to give oral evidence to the expert panel. The [...]

The post Parliamentary report refers to community pharmacy funding as ‘broken’  appeared first on Community Pharmacy England.

By |July 25th, 2023|Lexpos News|Comments Off on Parliamentary report refers to community pharmacy funding as ‘broken’ 

MHRA Drug Safety Update July 2023

A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 16 Issue 12 July 2023) has been published and includes articles on: Hyoscine hydrobromide patches (Scopoderm 1.5mg Patch or Scopoderm TTS Patch): risk of anticholinergic side effects, including hyperthermia. Codeine linctus: public consultation on the proposal to reclassify to a prescription-only medicine. [...]

The post MHRA Drug Safety Update July 2023 appeared first on Community Pharmacy England.

By |July 24th, 2023|Lexpos News|Comments Off on MHRA Drug Safety Update July 2023

OTCs and self-care could save NHS £1.7bn a year

PAGB, the consumer health care association, has released a report on the economic value of the over-the-counter sector. The report suggests that encouraging people to take a more a proactive approach to their health by promoting self-care could save the NHS over £1.7 billion per year by eliminating 25 million unnecessary GP appointments and five [...]

The post OTCs and self-care could save NHS £1.7bn a year appeared first on Community Pharmacy England.

By |July 24th, 2023|Lexpos News|Comments Off on OTCs and self-care could save NHS £1.7bn a year